StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Petros Pharmaceuticals's gross margin for the twelve months ending Dec 31, 2024 was 76.3%. For fiscal 2024 it was 76.3%, against 72.0% the year before. The highest annual figure on record is 79.5% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 202476.3%+4.3
FY2023Dec 31, 202372.0%+10.2
FY2022Dec 31, 202261.8%−17.7
FY2021Dec 31, 202179.5%+21.9
FY2020Dec 31, 202057.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2024Dec 31, 202463.5%−12.1
Q3 FY2024Sep 30, 202481.8%+7.6
Q2 FY2024Jun 30, 202476.8%−1.3
Q1 FY2024Mar 31, 202476.1%+86.5
Q3 FY2023Sep 30, 202375.6%−8.9
Q2 FY2023Jun 30, 202374.2%−6.6
Q1 FY2023Mar 31, 202378.1%−5.9
Q4 FY2022Dec 31, 2022-10.4%−94.6
Q2 FY2022Jun 30, 202284.5%+43.9
Q1 FY2022Mar 31, 202280.8%+9.2
Q2 FY2021Jun 30, 202184.0%+23.3
Q1 FY2021Mar 31, 202184.2%+28.0
Q4 FY2020Dec 31, 202040.6%–
Q3 FY2020Sep 30, 202071.7%–
Q2 FY2020Jun 30, 202060.7%–
Q1 FY2020Mar 31, 202056.2%–

More Petros Pharmaceuticals figures

See a number that looks wrong?